1. SWOT Analysis
  2. Healthcare
  3. Actelion SWOT Analysis

Actelion SWOT Analysis

Here is a detailed SWOT analysis of Actelion covering strengths, weaknesses, opportunities and threats.

Published by MBA Skool Team in Pharma and Healthcare category Last Updated: October 02, 2023Read time:

Actelion Strengths

  1. Actelion operates in niche segment of orphan diseases which have less competition
  2. Strong presence in over 60 plus markets
  3. Key drugs in the late stages of development in pipeline
  4. Longer patent life of key drugs
  5. Over 2500+ well trained employees

Above are the strengths in the SWOT Analysis of Actelion. The strengths of Actelion looks at the key internal factors of its business which gives it competitive advantage in the market and strengthens its position.

Actelion Weaknesses

  1. Limited presence in emerging markets
  2. They have only four blockbuster drugs

These were the weaknesses in the Actelion SWOT Analysis. The weaknesses of a brand are certain aspects of its business which it can improve.

Actelion Opportunities

  1. Diversify portfolio in specialty diseases
  2. Contract manufacturing of G.P diseases
  3. Market introduction of Cadazolid

Above we covered the opportunities in Actelion SWOT Analysis. The opportunities for any brand can include prospects of future growth.

Actelion Threats

  1. Increasing pressure to reduce prices in Europe
  2. Growing number of generic drugs
  3. Global economic slowdown

The threats in the SWOT Analysis of Actelion are as mentioned above. The threats for any business can be external factors which can negatively impact its business.

Hence this concludes the Actelion SWOT analysis.

Read Similar SWOT analysis

About Actelion

The table below gives the brand overview along with its target market, segmentation, positioning & USP

Actelion Overview
Parent Company

Actelion

Category

Pharmaceutical

Sector

Pharma and Healthcare

Tagline/ Slogan

Together we innovate

USP

Actelion operates in niche segment of orphan diseases

Actelion STP
Segmentation

Orphan diseases such as digital ulcers, gaucher’s disease

Target Market

Healthcare professionals operating in these areas

Positioning

Actelion is company which blends biotechnological innovation with pharmaceutical discipline


This article has been researched & authored by the Content & Research Team which comprises of MBA students, management professionals, and industry experts. It has been reviewed & published by the MBA Skool Team. The content on MBA Skool has been created for educational & academic purpose only.

Browse marketing analysis of more brands and companies similar to Actelion. This section covers SWOT Analysis along with Segmentation, Target Market, Positioning & USP of more than 2000 brands from over 20 industry sectors.

Continue Reading:


The brand names and other brand information used in the SWOT Analysis section are properties of their respective companies. The companies are not associated with MBA Skool in any way.
Edit the brand or add a new one to SWOT Analysis section : Contribute

Share this Page on:
Facebook ShareTweetShare on Linkedin